Acuity Brands Inc (NYSE:AYI) Announces Quarterly Earnings Results

Xavier Trudeau
Juillet 14, 2017

It improved, as 50 investors sold Acuity Brands, Inc. shares while 145 reduced holdings. Analysts expect next quarter's EPS to be $2.24 with next year's EPS projected to be $9.39. Acuity Brands has a 52 week low of $157.33 and a 52 week high of $280.89. Jagged Peak Energy Inc (JAG) has 0.00% since July 14, 2016 and is. It has underperformed by 47.88% the S&P500. The stock decreased 3.64% or $0.13 during the last trading session, reaching $3.44. GNW's SI was 13.91M shares in July as released by FINRA. Its up 10.65% from 5.35 million shares previously. Shares for $2.88M were sold by O'Connor William Bernard. The SI to Genworth Financial Incorporated's float is 2.8%. It closed at $138.35 lastly. AtriCure Inc. (NASDAQ:ATRC) has risen 53.35% since July 11, 2016 and is uptrending. It has outperformed by 237.58% the S&P500.

Since February 7, 2017, it had 0 insider buys, and 1 insider sale for $226,809 activity. Shares for $226,809 were sold by ROBINSON RAY M.

Capital World Investors, which manages about $397.60B US Long portfolio, decreased its stake in R.R. Donnelley & Sons Co by 8.30 million shares to 3.89 million shares, valued at $63.55M in 2016Q4, according to the filing. It also reduced Johnson Controls International stake by 90,792 shares and now owns 492,229 shares.

Clinton Group Inc grew its holdings by buying 1,284 shares an increase of 68.2% in the quarter. Its down 0.08, from 1.07 in 2016Q3. ZWJ Investment Counsel Inc. raised its position in Acuity Brands by 0.6% in the first quarter. 10,639 are held by Scott & Selber. Chevy Chase Trust Holdings, Inc. added to its position by buying 3 shares an increase of 0.0% as of 06/30/2017. Shareholders of record on Tuesday, July 18th will be given a $0.13 dividend. Marco Ltd Liability Company holds 0.58% or 14,500 shares. 21,000 are owned by Cornerstone Advsr. Loomis Sayles Com Limited Partnership has invested 0.02% of its portfolio in Acuity Brands, Inc. (NYSE:AYI) on Monday, October 31 to "Outperform" rating. Cleararc Capital owns 1,088 shares or 0.05% of their United States portfolio. Commerzbank Aktiengesellschaft FI purchased a new position in Acuity Brands during the fourth quarter valued at about $288,000. (NYSE:AYI). Stanley invested in 0.07% or 1,000 shares. The Company's portfolio consists of properties located in western Canada, specifically in the metropolitan areas of Edmonton, Calgary, Lethbridge and Red Deer, Alberta; Regina, Saskatchewan, and Kelowna, British Columbia. The legal version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/11/daiwa-sb-investments-ltd-has-1-19-million-stake-in-acuity-brands-inc-ayi.html. Cowen and Company's price target suggests a potential upside of 11.12% from the stock's previous close. Rbf Ltd Company owns 1,000 shares for 0.03% of their portfolio. It is down 0.00% since July 14, 2016 and is. Integrated Investment Consultants LLC boosted its position in Acuity Brands by 58.1% in the first quarter.

Among 17 analysts covering Acuity Brands Inc. (NYSE:AYI), 12 have Buy rating, 3 Sell and 3 Hold.

04/05/2017 - Acuity Brands Inc was downgraded to " by analysts at Goldman Sachs. The rating was maintained by Oppenheimer with "Outperform" on Thursday, April 7. As per Friday, January 27, the company rating was downgraded by TH Capital. The firm has "Buy" rating by Credit Agricole given on Thursday, February 25. The firm has "Underperform" rating by RBC Capital Markets given on Friday, October 23. Acuity Brands presently has an average rating of "Buy" and an average target price of $219.00. Robert W. Baird upgraded it to "Outperform" rating and $242 target in Tuesday, January 10 report. Robert W. Baird has "Neutral" rating and $265 target. As per Tuesday, September 22, the company rating was initiated by Wolfe Research. Roth Capital set a $150.00 price objective on shares of Acuity Brands and gave the company a sell rating in a research note on Tuesday, June 27th.

TESARO, Inc.is an oncology-focused biopharmaceutical company. The Company operates through North American segment. It is developing oncology-related product candidates, including rolapitant, niraparib and the product candidates under its immuno-oncology platform.

Investors sentiment decreased to 1.31 in Q4 2016. Its up 0.20, from 0.92 in 2016Q3. 15 funds opened positions while 36 raised stakes. Trillium Asset Mngmt Limited Liability Com, a Massachusetts-based fund reported 55,512 shares. (NASDAQ:ATRC). Victory Capital Mgmt Incorporated has invested 0.07% in AtriCure Inc. 2,440 were accumulated by Axa. Raymond James Assoc has invested 0% in AtriCure Inc. Blackhill owns 11,550 shares. (NYSE:AYI). Lakeview Prns Limited Liability Corp owns 1,483 shares or 0.29% of their USA portfolio. Trading volume was down 27.77% under the stocks average daily volume. Caisse De Depot Et Placement Du Quebec invested in 1.11% or 2.46 million shares. The stock rose 0.48% or $0.96 reaching $199.39 per share. Iguana Healthcare Management Llc acquired 75,000 shares as Medicines Co (MDCO)'s stock declined 20.30%. (NASDAQ:ATRC). Blackrock Institutional Na reported 829,491 shares. Moreover, Spectrum Asset (Nb Ca) has 0.9% invested in 3M Co (NYSE:MMM). 633,799 are held by Wells Fargo Mn.

Among 19 analysts covering Tesaro Inc (NASDAQ:TSRO), 12 have Buy rating, 1 Sell and 6 Hold. Therefore 69% are positive. Tesaro Inc had 42 analyst reports since August 24, 2015 according to SRatingsIntel. The rating was initiated by Susquehanna with "Positive" on Monday, February 13. As per Wednesday, July 12, the company rating was upgraded by BMO Capital Markets. The rating was maintained by Wedbush on Friday, August 5 with "Outperform". Roth Capital initiated the stock with "Neutral" rating in Thursday, August 25 report. The stock has "Buy" rating by Stifel Nicolaus on Wednesday, June 21. The Waters Parkerson & Company holds 24,104 shares with $5.57 million value, up from 11,558 last quarter. Shares for $1.21M were sold by ULLMAN MYRON E III on Wednesday, May 3.

D'autres rapports CampDesrEcrues

Discuter de cet article

SUIVRE NOTRE JOURNAL